Furthermore, in experiments involving intraperitoneal injection of puerarin (50 or 100 mg/kg) prior to renal ischemia-reperfusion in rats, it was observed that puerarin pretreatment reduced the expression of the renal fibrosis marker α-smooth muscle actin (α-SMA) in a dose-dependent manner. Here, ACTA1 is linked to renal fibrosis.